The drug development start-up TPP Global Development has agreed its first deal, in which it will collaborate with Edinburgh University to carry out preclinical development.
Times may be hard, but it remains possible to be innovative, Henry Chesbrough, the father of Open Innovation and ESADE Visiting Professor, tells Science|Business.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.